Positive research reports can often do wonders to a stock and that is what seems to have happened with the Checkpoint Therapeutics (NASDAQ:CKPT) stock, which has soared by 25% this morning. Justin Walsh, an analyst at B. Riley started covering the stock and gave it a...
